The effect of delivery via narrow-bore needles on mesenchymal cells

被引:53
作者
Agashi, Kapil [1 ]
Chau, David Y. S. [1 ]
Shakesheff, Kevin M. [1 ]
机构
[1] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Div Drug Delivery & Tissue Engn, Nottingham NG7 2RD, England
基金
英国生物技术与生命科学研究理事会;
关键词
apoptosis; caspase-3; protein; cell spreading; cell therapy; delivery; flow cytometry; injection; mesenchymal stem cell; n-acetyl-cysteine; ACUTE MYOCARDIAL-INFARCTION; STEM-CELLS; N-ACETYLCYSTEINE; MAMMALIAN-CELLS; THERAPY; TRANSPLANTATION; APOPTOSIS; INJECTION; DEATH; EXPANSION;
D O I
10.2217/17460751.4.1.49
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Aims: Recently, there have been numerous preclinical and human studies investigating the regenerative capacity of cell suspensions following their direct injection into a target organ: the fundamental parameters for successful (clinical) cell therapy. At present, limited data exist in the identification of factors important for the survival of these cells (i.e., morphology, viability and proliferation rates) during and following their ejection via narrow-bore needles. Materials & methods: Primary murine mesenchymal stem cells (mMSCs) were isolated, expanded and processed into a concentrated cell suspension consisting of either HBSS or HBSS supplemented with the antioxidant n-acetyl-cysteine. This suspension was then ejected from a 10 mu l Hamilton syringe, via a variety of bore-sized needles, at different ejection rates. Cell characteristics including viability, spreading and attachment, apoptosis and proliferative ability were then assessed. Results: Following manipulation within a syringe, a decrease in the viability and cell spreading of mMSCs and a concurrent increase in the production of the caspase-3 protein, an early regulatory event in apoptosis, occurs. These detrimental effects were found to be increased when the cells were left in the syringe chamber for increased periods of time, and were similar at 5 mu l/min and 1 mu l/min ejection rates. However, on increasing the needle bore diameter, a significant reduction in these characteristics was observed. By comparison, mMSCs that were left to stand at room temperature (18-20 degrees C), but were not manipulated within a syringe, showed a significantly greater viability compared with manipulated cells. However, cells kept at 4 degrees C demonstrated a decreased viability compared with manipulated cells. When the mMSC were incubated with n-acetyl-cysteine, a known antioxidant, no significant change in caspase-3 production or cell spreading was observed. Conclusions: This study highlights potential parameters, such as minimizing the time period the cells are within the syringe and the use of wider-bore needles, involved in maintaining the high viable cell density required for the delivery of cell suspensions for cell therapy applications.
引用
收藏
页码:49 / 64
页数:16
相关论文
共 44 条
  • [1] Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer
    Allahham, A
    Stewart, P
    Marriott, J
    Mainwaring, DE
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 270 (1-2) : 139 - 148
  • [2] A FLOW CYTOMETRIC STUDY OF HYDRODYNAMIC DAMAGE TO MAMMALIAN-CELLS
    ALRUBEAI, M
    EMERY, AN
    CHALDER, S
    GOLDMAN, MH
    [J]. JOURNAL OF BIOTECHNOLOGY, 1993, 31 (02) : 161 - 177
  • [3] N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology
    Arakawa, Motoki
    Ito, Yoshihisa
    [J]. CEREBELLUM, 2007, 6 (04) : 308 - 314
  • [4] Adipose-derived stem cells are a source for cell therapy of the corneal stroma
    Arnalich-Montiel, Francisco
    Pastor, Silvia
    Blazquez-Martinez, Alejandro
    Fernandez-Delgado, Jorge
    Nistal, Manuel
    Alio, Jorge L.
    De Miguel, Maria P.
    [J]. STEM CELLS, 2008, 26 (02) : 570 - 579
  • [5] Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution
    Barbash, IM
    Chouraqui, P
    Baron, J
    Feinberg, MS
    Etzion, S
    Tessone, A
    Miller, L
    Guetta, E
    Zipori, D
    Kedes, LH
    Kloner, RA
    Leor, J
    [J]. CIRCULATION, 2003, 108 (07) : 863 - 868
  • [6] Role of imaging in cardiac stem cell therapy
    Beeres, Saskia L. M. A.
    Bengel, Frank M.
    Bartunek, Jozef
    Atsma, Douwe E.
    Hill, Jonathan M.
    Vanderheyden, Marc
    Penicka, Martin
    Schalij, Martin J.
    Wijns, William
    Bax, Jeroen J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (11) : 1137 - 1148
  • [7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [8] Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases
    Burt, Richard K.
    Loh, Yvonne
    Pearce, William
    Beohar, Nirat
    Barr, Walter G.
    Craig, Robert
    Wen, Yanting
    Rapp, Jonathan A.
    Kessler, John
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (08): : 925 - 936
  • [9] CELL-DEATH (APOPTOSIS) IN CELL-CULTURE SYSTEMS
    COTTER, TG
    ALRUBEAI, M
    [J]. TRENDS IN BIOTECHNOLOGY, 1995, 13 (04) : 150 - 155
  • [10] Limbal epithelial stem cell therapy
    Daniels, Julie T.
    Notara, Maria
    Shortt, Alex J.
    Secker, Genevieve
    Harris, Anna
    Tuft, Stephen J.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (01) : 1 - 3